StockData
Inventiva S.A. logo

Inventiva S.A. (IVA) stock

IVANasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as IVEVF
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Apr 8, 2026Score 1/30
$3.22−0.10 (-3.01%)

Close on Nov 17, 2026Market cap $622.22MP/E –Yield –

Earnings

Inventiva's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.

Next report
–
Not yet scheduled
Revenue
–
EPS
–
Latest guidance
None
No outlook given in releases

Quarterly results

Revenue and earnings per share from each of Inventiva's earnings releases, newest first

QuarterReportedRevenueYoYEPSSource
Q2 FY2026ended Jun 30, 2026Jul 29, 2026after the close–––Release
Q4 FY2025ended Dec 31, 2025Feb 17, 2026before the open–––Release
Q2 FY2025ended Jun 30, 2025Sep 29, 2025before the open–––Release
Q4 FY2024ended Dec 31, 2024Feb 10, 2025after the close–––Release
Q2 FY2024ended Jun 30, 2024Sep 25, 2024after the close–––Release
Q4 FY2023ended Dec 31, 2023Mar 27, 2024after the close–––Release
Q2 FY2023ended Jun 30, 2023Sep 28, 2023after the close–––Release
Q4 FY2022ended Dec 31, 2022Feb 14, 2023after the close–––Release
Q2 FY2022ended Jun 30, 2022Sep 22, 2022before the open–––Release
Q4 FY2021ended Dec 31, 2021Mar 7, 2022after the close–––Release

Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.

Guidance

Inventiva has not given guidance in its releases

Many companies give their outlook only on the conference call or not at all. When Inventiva puts a forecast in an earnings release, it is listed here with the exact sentence.

Press releases

Releases Inventiva filed with the SEC as exhibits to Form 8-K or 6-K

  1. 6-K
  2. 6-K
  3. 6-K
  4. 6-K
  5. 6-K
  6. 6-K
  7. 6-K
  8. 6-K
  9. 6-K
  10. 6-K
  11. 6-K
  12. 6-K
  13. 6-K
  14. 6-K
  15. 6-K

See a number that looks wrong?